Exchange: NASDAQ·Updated 07:40 AM EDT

EVAX News

News
all
press releases
Evaxion Biotech Q2 2026 Earnings Call: Complete Transcript
On Thursday, Evaxion Biotech (NASDAQ:EVAX) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensiveread more...
Benzinga
Evaxion Appoints Helen Tayton-Martin As Chief Executive
Stocktwits
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation PR Newswire VANCOUVER, BC, Oct. 17, 2025...
PR Newswire
Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happened
The company said it will receive a cash payment of $7.5 million, in addition to future milestone payments of up to $592 million.
Stocktwits

Advertisement|Remove ads.